Pharmaceutical Economics and Policy

Program Objective: This program promotes teaching and research on issues related to pharmaceuticals and the pharmaceutical industry. It trains professionals seeking careers in the area, and supports the work of industry and government.

Director:
William S. Comanor

Associate Directors:
Stuart O. Schweitzer
Michael O. Intriligator

Telephone : (310) 206-1641
Fax: (310) 825-3317

The Seminar begins its 21st year. As in prior years, we meet in the Dean's Conference Room (16-059 CHS) at the UCLA School of Public Health on selected Thursday afternoons at 4:30pm. 

1. October 7, 2010

William S. Comanor
UCLA and UCSB

Title: "An Introduction to the Economics of the Pharmaceutical Industry"

2. October 14, 2010

Eric Helland
Claremont McKenna College

Title: "Tort Liability and the Market for Prescription Drugs"

3. October 28, 2010

David Ridley
Duke University

Title: "Pharmaceutical Pricing Strategy under Inflation Constraints"

4. November 18, 2010

Don Light
Stanford University and the University of Medicine and Dentistry of New Jersey

Title: "The Epidemic of Adverse Drug Reactions and the Risk Proliferation Syndrome"

5.         January 20, 2011                    

Anup Malani
University of Chicago
 
Title:   "Accounting for Differences among Patients in the FDA Approval Process"

6.         February 10, 2011                  

Brett Wendling
U.S. Federal Trade Commission.

Title:     "Entry Threats and Pricing in the Generic Drug Industry”
                       

  7.       March 3, 2011

Stuart O. Schweitzer and William S. Comanor
 UCLA

Title:   "Pharmaceutical Mergers and Innovation"

8.       April 21, 2011

Joe Dimasi
Tufts University
 
Title:     “Does Size Matter: Success Rates for Investigational Drugs”
           
9.         May 12, 2011

Scott Stern
MIT

Title:     “Finding the Endless Frontier: the Determinants of Pharmaceutical Innovation"

10.     “May 26, 2011

Joel Hay
USC 

Title:     “The Determination of Pharmaceutical markets: a Review of the  Lundbeck v. FTC Decision”

2010-11 Schedule

UCLA School of Public Health
Department of Health Services
2009-2010

1. October 8, 2009
William S. Comanor
UCLA and UCSB

Title: "An Introduction to the Economics of the Pharmaceutical Industry"

2. October 22, 2009
Stuart O. Schweitzer
UCLA

Title: "World-wide Drug Pricing"

3. November 5, 2009
Neeraj Sood
USC

Title: "Medicare Part D and Pharmaceutical Research"

4. December 3, 2009
Dominick Esposito
Mathematica Policy Research

Title: "Crossing the Doughnut Hole: The Effects of the Medicare Drug Coverage Gap for Patients who Require High-Cost Medications"

5. January 7, 2010
Guy David
University of Pennsylvania

Title: "The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Effects and Regulation"

6. February 11, 2010
Marc Berger
Eli Lilly & Co.

Title: "Comparative Effectiveness and Health Technology Innovation”

7. March 4, 2010
Gerald Kominski
UCLA

Title: "The LA County Prescription Drug Discount Card: Is this good public policy?"

8. April 1, 2010
Michael Maloney
Clemson University

Title: “The Effect of Price on Pharmaceutical R&D”

9. April 29, 2010 [changed from April 22]
Henry Grabowski
Duke University

10. May 6, 2010
Subramaniam (Subbu) Ramanarayanan
Anderson School at UCLA

Title: “Health Insurance Industry Consolidation: Impact on Pharmaceutical Pricing"

2009-10 Schedule

UCLA School of Public Health
Department of Health Services
2008 - 2009

SEMINAR ON PHARMACEUTICAL ECONOMICS AND POLICY

1. October 2, 2008

William S. Comanor
UCLA and UCSB

Title: “An Introduction to the Economics of the Pharmaceutical Industry”

2. October 23, 2008

Stuart O. Schweitzer
UCLA

Title: “Assuring Drug Quality: Lessons from the Heparin Recall”

3. November 6, 2008

Ben Zycher
Manhattan Institute for Policy Research

Title: “Industry and Non-industry Contributions to Pharmaceutical Research”

4. November 20, 2008

Michelle Gittleman
Rutgers University Business School

Title: “Are Licensing Markets Local? An Analysis of the Geography of Vertical Licensing Agreements in Bio-pharmaceuticals”

5. January 8, 2009

F. M. Scherer
Harvard University

Title: "Markets and Uncertainty in Pharmaceutical Development"

6. January 29, 2009

Thomas Rice
UCLA

Title: "Reducing the Number of Drug Plans for Seniors: Preliminary Results from a Series of Projects”

7. February 19, 2009

Stephen Crystal
Rutgers University Medical School

Title: "Who Pays the Piper: Depression Treatment among the US Elderly and the Impact of Cost Sharing"

8. March 5, 2009

Dana Goldman
The RAND Corporation

Title: “Me-too Innovation in Pharmaceutical Markets”

9. April 23, 2009

Richard Nagareda
Vanderbilt University Law School

Title: “FDA Pre-emption: When Tort Law Meets the Administrative State "

10. May 21, 2009

Anna Levine
Harvard University

Title: “Licensing and Scale Economies in the Biotechnology Pharmaceutical Industry ”

PDF version

UCLA School of Public Health
Department of Health Services
2007 - 2008

1. October 4, 2007

Stuart O. Schweitzer
UCLA
Title: "The Impact of Genetic Testing on the Pharmaceutical Industry"

2. October 18, 2007

William S. Comanor
UCLA and UCSB
Title: "An Introduction to the Economics of the Pharmaceutical Industry"

3. November 1, 2007

Kim Jinnett
Integrated Benefits Institute, San Francisco
Title: "A Broader Reach to Pharmacy Plan Design"

4. December 6, 2007

Ben Zycher
Manhattan Institute for Policy Research
Title: "The Human Cost of Federal Price Negotiations: the Medicare Prescription Drug Benefit and Pharmaceutical Innovation"

5. January 17, 2008

Joel Hay
University of Southern California

Title: "How to Measure Drug Costs in Cost-effectiveness Analysis?"

6. February 7, 2008

Ariel Katz
University of Toronto, Canada

Title: "Pharmaceutical Lemons: Innovation and Regulation in the Drug Industry"

7. February 28, 2008

Randall Lutter
Deputy Commissioner for Policy, FDA

Title: "Managing Conflict of Interest Issues among FDA Advisors"

8. April 10, 2008

David Levine
Washington University in St. Louis

Title: "Patents and Monopoly in Pharmaceuticals"

9. April 24, 2008

Richard Frank
Harvard University

Title: "Rethinking FDA Regulation of Biologics "

10. May 8, 2008

Joshua Ofman
AMGEN
Title: "Evolving Policies towards the Biotechnology Industry"

All meetings are held in the Dean's Conference Room 16-059 CHS at the UCLA School of Public Health on Thursday afternoons from 4:30 PM - 6:30 PM. There will be dinner with the speaker at the UCLA Faculty Center following the Seminar.

PDF version

---

UCLA School of Public Health
Department of Health Services
2006 - 2007

1. October 12, 2006

William S. Comanor
UCLA and UCSB
Title: "An Introduction to the Economics of the Pharmaceutical Industry"

2. October 19, 2006

Gerard Viens
ESSEC, Paris
Title: "Pharmaceutical economics and pricing policy in France"

3. November 16, 2006

Iain Cockburn
Boston University and NBER
Title: "Is the Pharmaceutical Industry in a Productivity Crisis?"

4. November 30, 2006

Darren Filson
Claremont Graduate University
Title: "The Impacts of Price Controls on the Performance of the Research-Based Pharmaceutical Industry"

5. January 25, 2007

Jerome Hoffman
School of Medicine, UCLA
Title: "Industry Sponsored Clinical Research - Is it Possible to Restore Trust?"

6. February 8, 2007

Jason Doctor
USC
Title: "Should Health Insurers Fund Life-style Drugs?"

7. March 8, 2007

David Meltzer
University of Chicago
Title: "The Institute of Medicine Report on Drug Safety and the FDA."

8. April 26, 2007

Jennifer Malin
Amgen
Title: "Cost Effectivelness Analysis and Public Policy"

9. May 17, 2007
Scott Hemphill
Columbia University
Title: "Paying for Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem"

10. May 31, 2007

Geoffrey Joyce
RAND
Title: "The Implications of Government Imposed Drug Discounts"

UCLA School of Public Health
Department of Health Services
2005- 2006

1. October 6, 2005

William S. Comanor
UCLA and UCSB

Title: "An Introduction to the Economics of the Pharmaceutical Industry"

2. November 3, 2005

Stephen Marder
UCLA

Title: "Academic, Industry, and Government Collaboration in Drug Development"

3. November 10, 2005

Alan Garber
Stanford University

Title: "Barriers to Health Care Productivity"

4. December 1, 2005

John Rizzo
State University of New York, Stoneybrook

Title: "Generic Scrip Share and the Price of Brand Name Drugs"

5. January 19, 2006

Michael Nichol
USC

Title: "Patient Compliance with Pharmaceuticals as a Predictor of Health Care Costs"

6. February 16, 2006

Jack Needleman
UCLA

Title: "The Off-Label Use of Pharmaceuticals: Conflicting Incentives for Physicians and Drug Companies"

7. March 2, 2006

Thomas Abbott
Medstat Corporation

Title: "The Cost of US Pharmaceutical Price Reductions: a Financial Simulation Model of R&D Decisions"

8. April 27, 2006

Darius Lakdawalla
RAND Corporation

Title: "Intellectual Property and Marketing"

9. May 18, 2006

Alan Mathios
Cornell University

Title: "The Impact of DTC Advertising on the Demand for Pharmaceuticals: the cases of smoking cessation and cholesterol reducing drugs"

10. June 1, 2006

Dean Jamison
University of California, San Francisco

Title: "A Friendly Review of STRONG MEDICINE by Michael Kramer and
Rachael Glennerster"